References
Williamson BD, et al. Drugs Aging 2: 461–468, 1992
Battershill PE, et al. Drugs Aging 4: 63–86, 1994
Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico. Lancet 1: 397–402, 1986
Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico. Lancet 2: 871–874, 1987
ISIS-2 Collaborative Group. Lancet 2: 349–360, 1988
EMERAS Collaborative Group. Lancet 342: 767–772, 1993
Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico. Lancet 336: 65–71, 1990
International Study Group. Lancet 336: 71–75, 1990
ISIS-3 Collaborative Group. Lancet 339: 753–770, 1992
GUSTO Investigators. N Engl J Med 329: 673–682, 1993
Krumholz HM, et al. N Engl J Med 327: 7–13, 1992
Collins R. Circulation 84: 230, 1991
White HD. Lancet 340: 221–222, 1992
Lee KL, et al. Ann Intern Med 120: 876–881, 1994
Ridker PM, et al. Ann Intern Med 120: 882–885, 1994
Farkouh ME, et al. Ann Intern Med 120: 886–888, 1994
Pharm Bus News 10: 22–23, 16 May 1994
Rights and permissions
About this article
Cite this article
Streptokinase: still useful for elderly patients with acute MI. Drugs Ther. Perspect 4, 5–7 (1994). https://doi.org/10.2165/00042310-199404020-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199404020-00002